Maash S.A

Our first application is in life sciences: an advanced micropump platform for Organ-on-chip. A promising new testing method in preclinical drug studies is Organ-on-chip (OoC), aimed at providing more human relevance and reducing animal testing. Recent studies show high predictive value of OoC: a liver study, for example, showed that 7 out of 8 drugs where not safe while they were originally reported safe by traditional animal testing. However, the adoption of OoC in the pharmaceutical industry is currently still very low, for which one of the main reasons is difficulty to use. To mimic the human body well, the chip needs a fluid flow, but current systems providing adequate flow require lots of tubes between the chip and the pump, which is a hassle to work with. Our advanced micropump platform creates the right flow to mimic the environment of the human body, while enabling ease of use. This is facilitated by our patented Magnetic Artificial Cilia technology, that can create a fluid flow without any direct physical connections like tubing. Such a solution is yet non-existent in the market today.